BAKER BROS. ADVISORS LP – Ultragenyx Pharmaceutical Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$19.50M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
-30.59%
quarter
Ultragenyx Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -8.59M | $41.41 | 470.97K | |
| Q2 2022 | share | Increase | +5.97% | 26.53K shares | -4.17M | $59.66 | 470.97K |
| Q1 2022 | share | 0.00% | 0 shares | -5.09M | $72.62 | 444.44K | |
| Q4 2021 | share | 0.00% | 0 shares | -2.71M | $84.25 | 444.44K | |
| Q3 2021 | share | 0.00% | 0 shares | -2.29M | $90.19 | 444.44K | |
| Q2 2021 | share | 0.00% | 0 shares | -8.22M | $95.35 | 444.44K | |
| Q1 2021 | share | 0.00% | 0 shares | -10.92M | $113.86 | 444.44K | |
| Q4 2020 | share | Increase | 0.00% | 444.44K shares | 61.52M | $138.43 | 444.44K |
| Q3 2017 | share | Decrease | -100.00% | -25K shares | -1.55M | $53.26 | 0 |
| Q2 2017 | share | Decrease | -50.00% | -25K shares | -1.83M | $62.11 | 25K |
| Q1 2017 | share | 0.00% | 0 shares | -127K | $67.78 | 50K | |
| Q4 2016 | share | Decrease | -50.00% | -50K shares | -3.57M | $70.31 | 50K |
| Q3 2016 | share | Decrease | -9.82% | -10.89K shares | 1.67M | $70.94 | 100K |
| Q2 2016 | share | Decrease | -10.49% | -13K shares | -2.42M | $48.91 | 110.89K |
| Q1 2016 | share | 0.00% | 0 shares | -6.05M | $63.31 | 123.89K |